display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - HR positive
la/mBC - HR-positive - 2nd line (L2)
alpelisib plus fulvestrant SOLAR-1 ... SOLAR-1 ...

Study type: